The antioxidative role of selenium in pathogenesis of cancer of the female reproductive system

Neoplasma

Volumn 54, Issue 5, 2007, Pages 374-378

  Piekutowski, K ^a   Makarewicz, R ^b   Zachara, B A ^c  

^a Regional Oncology Centre Bydgoszcz   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Cancer of reproductive system; Carcinogenesis; Glutathione peroxidase; Reactive oxygen species; Selenium

Indexed keywords

GLUTATHIONE PEROXIDASE; SELENIUM; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARY CANCER; TISSUE LEVEL; UTERINE CERVIX CANCER; UTERUS CANCER; BLOOD; FEMALE GENITAL TRACT TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; REFERENCE VALUE;

ADULT; ANTIOXIDANTS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; SELENIUM;

EID: 35448982377     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. FANTEL AG. Reactive oxygen species in developmental toxicity: A review and hypothesis. Teratology 1996; 53: 196-217 (Pubitemid 26190892)
2. HALLIWELL B, GUTTERIDGE JM. Free radicals in biology and medicine., New York: Oxford University Press, 1999.
3. TSAN MF. Superoxide dismutase and pulmonary oxygen toxicity: Lessons from transgenic and knockout mice (Review). Int. J. Mol. Med. 2001; 7: 13-19
4. YU BP. Cellular defences against damage from reactiveoxygen species. Physiol. Rev. 1994; 74: 139-162
5. ZACHARA BA. Mammalian selenoproteins. J. Trace Elem. Electrolytes Health Dis. 1992; 6: 137-151
6. HALLIWELLL B. Antioxidants in human health and disease. Annu. Rev. Nutr. 1996; 16: 33-50
7. YOUNG IS, WOODSIDE JV. Antioxidants in health and disease. J. Clin. Path ol. 2001; 54: 176-186
8. SHAMBERGER RJ, TYTKO S, WILLIS CE. Selenium in the blood of normals, cancer patients with other diseases. Clin. Chem. 1973; 19: 672-675
9. SHAMBERGER RJ, TYTKO SA, WILLIS CE. Antioxidants and cancer. VI. Selenium and age-adjusted human cancer mortality. Arch. Environ. Health. 1976; 31: 231-235
10. SHAMBERGER RJ, WILLIS CE. Selenium distribution and human cancer mortality. C.R.C. Crit. Rev. Clin. Lab. Sci. 1971; 2: 211-221
11. CLARK LC, CANTOR KP, ALLAWAY WH. Selenium in forage crops and cancer mortality in US counties. Arch. Environ. Health. 1991; 46: 37-42
12. SCHRAUZER GN. Inorganic and nutritional aspects of cancer. A conference report. Bioinorg. Chem. 1977; 7: 359-365
13. SCHRAUZER GN, WHITE DA, SCHNEIDER CJ. Cancer mortality correlation study - III: Statistical associations with dietary selenium intakes. Bioinorg. Chem. 1977; 7: 23-34
14. CZUCZEJKO J, ZACHARA BA, STAUBACH-TOPCZEWSKA E, et al. Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases. Acta Biochim Pol. 2003; 50(4): 1147-1154 (Pubitemid 38608842)
15. WATKINSON JH. Fluorometric determination of selenium in biological material with 2,3-diamnonaphthalene. Anal. Chem. 1966; 38: 92-97
16. PAGLIA DE, VALENTINE WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967; 70: 158-169
17. ZACHARA BA, SZEWCZYK-GOLEC K, TYLOCH J et al. Blood and tissue selenium concentrations and glutathione peroxidase activities in patients with prostate cancer and benign prostate hyperplasia. Neoplasma. 2005; 52: 248-254
18. DIWADKAR-NAVSARIWALA V, DIAMOND AM. The link between selenium and chemoprevention: a case for selenoproteins. J Nutr. 2004; 134: 2899-2902
19. DIWADKAR-NAVSARIWALA V, PRINS GS, SWANSON SM et al. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A. 2006; 103: 8179-8184
20. YU SY, CHU YUJ, GONG XL et al. Regional variation of cancer mortality incidence and its relation to selenium levels in China. Biol. Trace Elem. Res. 1985; 7: 21-29
21. TORUN M, ALDEMIR H, YARDIM S. Serum selenium levels in various cancer types. Trace Elem. Electrolytes. 1995; 12: 186-190
22. KAUPPILA A, SUNDSTROM H, KORPELA H et al. Serum selenium and gynecological cancer: Effect of selenium supplementation on plasma malondialdehyde and serum glutathione pertoxidase. In: Thaler Dao H et al, editors. Icosanoids and Cancer. New York: Raven Press, 1984: 263-266
23. SUNDSTROM H, KORPELA H, VIINIKKA L, , et al. Serum selenium and glutathione peroxidase, and plasma lipid peroxides in uterine, ovarian or vulvar cancer, and their responses to antioxidants in patients with ovarian cancer. Cancer Lett. 1984; 24: 1-10
24. MILNERT JA. Effect of selenium on virally induced and transplantable tumor models. Fed. Proc. 1985; 44: 2568-2572
25. MACIA̧G A, MARCHALUK-WIŚNIEWSKA E, ZACHARA BA, , et al. The distribution of selenium and glutathione peroxidase in malignant tissue of breast cancer patients. In. Mengen- und Spurenelemente. 18. Arbeitstagung, 4. und 5. Dezember 1998, 498-505.
26. ZACHARA BA, MARCHALUK-WIŚNIEWSKA E, MACIA̧G A, et al. Decreased selenium concentration and glutathione peroxidase activity in blood and increase of these parameters in malignant tissue of lung cancer patients. Lung 1997; 175: 321-332
27. MILNER JA. Selenium and the transplantable tumor. J. Agric. Food Chem. 1984; 32: 436-442
28. THOMPSON HJ, RONAN AH. Differencves in selenium concentrations in target tissues and their relevance to its anticarcinogenicity. Nutr. Res. 1990; 10: 81-89